Operators reduced radiation dose 48 percent with no loss in volumes or interventions using a novel algorithm in the catheterization laboratory, researchers reported online April 16 in the Journal of the American College of Cardiology: Cardiovascular Interventions.

The learning curve for transradial PCI in the U.S. is “relatively shallow” and similar to that for operators outside the U.S., according to an analysis of CathPCI Registry data that was published online April 22 in Circulation.

ACE is proud to be referenced as a pioneer of accreditation standards in the new health policy statement from the American College of Cardiology, American Heart Association, and Society for Cardiovascular Angiography (ACC/AHA/SCAI). The policy statement defines new standards for structured reporting of clinical and operational data in the cardiac catheterization laboratory. With the new policy statement, ACC/AHA/SCAI notes the “increasing importance of accreditation of cardiac catheterization laboratories.”

Cardiologists whose patients are not good candidates for dual antiplatelet therapy (DAPT) may have an option beyond a bare metal stent. Results from a trial presented March 31 at the American College of Cardiology (ACC) scientific session in Washington, D.C., showed that treatment with a drug-eluting stent (DES) in combination with a personalized DAPT approach appeared to be safe and effective at one year.

The Detroit Medical Center (DMC) is the first in the Midwest to use a new, state-of-the-art system for treating Coronary Artery Disease (CAD).

OrbusNeich today announced the completion of enrollment in the prospective, multicenter, all-comers REMEDEE Registry (Multicenter, Prospective, Clinical Outcomes After Deployment of the Abluminal Sirolimus Coated Bio-Engineered Stent (Combo Bio-Engineered Sirolimus Eluting Stent) Post Market Registry) to evaluate the COMBO Stent for the treatment of coronary lesions in the setting of routine clinical care. The registry enrolled 1,000 patients at nine European high-volume percutaneous coronary intervention centers in France, Latvia, Luxembourg, The Netherlands, United Kingdom and Spain.

WASHINGTON, DC – March 27, 2014 –A new angiographic analysis of the CHAMPION PHOENIX trial examined the incidence and impact of stent thrombosis (ST) in patients undergoing percutaneous coronary intervention (PCI). Results of the study were released today and will be presented March 30 at the American College of Cardiology 63rd Annual Scientific Session.

WASHINGTON, D.C., March 28, 2014 – With the unmatched flexibility to measure radiation peak skin dose in real time, Toshiba America Medical Systems, Inc.’s Dose Tracking System is the latest advancement in optimizing dose management for its InfinixTM-i cardiovascular X-ray systems during adult and pediatric interventional procedures.